Strategic expansion Yonalink has secured notable traction with Hadassah Medical Organization and announced the platform launch for EHR-to-EDC data integration, signaling a growing customer base in large healthcare institutions and academic medical centers—an opportunity to target similar large hospitals and research networks with scalable data integration solutions.

Funding momentum With a $6M initial funding round completed in late 2022, Yonalink has capital to scale globally and expand its EHR-to-EDC platform, suggesting a window for partner channels and resellers to accelerate go-to-market efforts and cross-sell to new regions and CRO networks.

Clinical data focus The core offering automates EHR to EDC data capture and AI-driven CRF mapping to reduce manual workload and improve data quality, addressing critical pain points for trial sites and sponsors—a strong sales angle for CROs, site networks, and pharma sponsors seeking efficiency gains.

Real-time value Real-time data collection and streaming capabilities position Yonalink as a strategic partner for trials requiring rapid data flow and reduced burnout among clinical staff, enabling outbound messaging to sites experiencing workload strain and sponsors aiming for faster study timelines.

Growth signals Public announcements of platform launch and enterprise deployment, along with a mid-size revenue profile and international reference (Hadassah), indicate potential for enterprise upsell, feature expansion (AI CRF mapping improvements), and expansion into additional hospital systems and research networks.